DWM
WST icon

Destination Wealth Management’s West Pharmaceutical WST Stock Holding History

Destination Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-60
Closed -$5K – 661
2018
Q1 		$5K Buy
+60
New +$5.61K ﹤0.01% 458

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Destination Wealth Management's WST Position: Q2 2018 in Review

Destination Wealth Management sold out of West Pharmaceutical (WST) in Q2 2018, closing a stake of 60 shares — an estimated $5K sold.

Destination Wealth Management first reported a position in WST in Q1 2018 and held it in 1 quarter. The position peaked at $5K in Q1 2018. 324 funds tracked by Wall St. Rank hold WST as of Q2 2018.

  • Destination Wealth Management reported no remaining West Pharmaceutical position as of Q2 2018 after selling out during the quarter.
  • Destination Wealth Management sold 60 West Pharmaceutical shares in Q2 2018, an estimated $5K.
  • Destination Wealth Management first reported a position in West Pharmaceutical in Q1 2018 and held it in 1 quarter.
  • Destination Wealth Management's West Pharmaceutical position peaked at $5K in Q1 2018.
  • 324 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2018.

Based on Destination Wealth Management's 13F filing for Q2 2018, filed 31 Jul 2018.